Abcam PLC (LSE:ABC) - Share price


Stock Report

Abcam PLC ABC

Last Price
GBX1,378.00

Day Change
32.00|2.38%

As of 10/12/2019
18:45:11 GMT | GBX
Minimum 15 Minutes Delay.

Last Close1,346.00p
Day Range1,340.00 - 1,378.00
Mkt Cap2.77Bil
52-Wk Range1,006.00 - 1,523.00
Yield %0.90
ISINGB00B6774699
Volume382,841
P/E61.73
P/S0.11
P/CF0.41

Share Price

Total Returns 10/12/2019

 Chg (%)  
More ...
Abcam PLC10.15 
FTSE 100 TR GBP-1.62
 
Financials
201720182019
More ...
Income Statement
Turnover217.10233.20259.90
Operating Profit55.1075.4077.00
Net Profit42.4062.2045.00
Reported EPS20.7030.2021.80
Balance Sheet
Current Assets143.50159.90171.80
Non Current Assets218.20254.90274.90
Total Assets361.70414.80446.70
Current Liabilities32.6049.0045.30
Total Liabilities---
Total Equity307.10351.70384.80
Cash Flow
Operating Cash Flow76.5072.9083.70
Net Change in Cash15.705.00-4.40

Regulatory News

DateAuthor Headline
24/04/2014Holly Cook 3 VCTs for Enjoying Tax-Free Returns
ASK THE EXPERT: Harry Driscoll of Chelsea Financial Services explains why VCTs can be so attractive, and offers some ideas for investors interested in this area
20/02/2014Emma Wall Top Managers' Favourite Small-Cap Stocks
These five UK small-cap stocks have all caught the attention of our highest-rated fund managers
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
29/11/2019DGavin Hilary James Wood1,326.0011146.00
29/11/2019DMr. Alan Thomas Hirzel1,326.0039517.00
04/11/2019Exercise of OptionGavin Hilary James Wood0.2059,681119.00
04/11/2019Sale of OptionGavin Hilary James Wood1,171.1328,126329,393.00

Company Profile

Abcam PLC is a biotechnology company engaged in developing antibodies for life science research and clinical communities. It works on regulatory molecules and proteins in biological pathways to treat diseases like cancer and immune deficiency disorders.

Sector

Biotechnology

Index

FTSE AIM UK 50 ,FTSE AIM 100 ,FTSE AIM All-Share

Next Event 04/03/2020

Half-Yearly Results
Ratios
Comp
More ...
PER (E)61.24
Div Yld (E)0.91
PEG (E)0.00
ROCE19.18
Op Mrgn0.30
EPS Grwth-0.09
Dividends
PreviousLatest
More ...
Record Date15/03/1908/11/19
Ex-Div14/03/1907/11/19
Paid12/04/1929/11/19
Amnt3.558.58
Directors
More ...
Non-Executive Director, Deputy ChairmanDr. Jonathan Simon Milner
Non-Executive DirectorLady Louise Alexandra Virginia Charlotte Patten of Wincanton
Non-Executive DirectorMr. Giles Francis Bertram Kerr
Non-Executive Director, ChairmanMr. Peter Vance Allen
Executive Director, Chief Financial OfficerGavin Hilary James Wood
Executive Director, Chief Executive OfficerMr. Alan Thomas Hirzel
Non-Executive DirectorMs. Mara Glickman Aspinall
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.